NCT04431687View on ClinicalTrials.gov

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

July 24, 2020

Study Completion Date

October 26, 2020

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

CKD 501

QD, PO

DRUG

D759, D150

QD, PO

DRUG

CKD-501, D759, D150

QD, PO

Trial Locations (1)

13497

CHA Bundang Medical Center, CHA University, Seongnam-si

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY